Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists
A series of 2-heteroaryl-4-arylimidazoles with potent in vitro activity at the NPY5 receptor was developed. Introduction of electron-withdrawing groups on the 4-aryl ring led to a significant improvement of in vitro potency. Several analogues from this series had anorectic activity in rodent feeding...
Gespeichert in:
| Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2003-10, Vol.13 (20), p.3593-3596 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3596 |
|---|---|
| container_issue | 20 |
| container_start_page | 3593 |
| container_title | Bioorganic & medicinal chemistry letters |
| container_volume | 13 |
| creator | ELLIOTT, Richard L OLIVER, Robert M MACK, Christine M CASSELLA, James V LAFLAMME, Janet A GILLASPY, Melissa L HAMMOND, Marlys HANK, Richard F MAURER, Tristan S BAKER, Demetria L DASILVA-JARDINE, Paul A STEVENSON, Ralph W |
| description | A series of 2-heteroaryl-4-arylimidazoles with potent in vitro activity at the NPY5 receptor was developed. Introduction of electron-withdrawing groups on the 4-aryl ring led to a significant improvement of in vitro potency. Several analogues from this series had anorectic activity in rodent feeding models, but were also found to have undesired behavioral effects in spontaneous locomotor activity. |
| doi_str_mv | 10.1016/S0960-894X(03)00747-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75698113</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75698113</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-3bb124a254793ae5c5b5d9f0b108b14b6cdfe926c37dc667ebc79e367adcb47a3</originalsourceid><addsrcrecordid>eNpFkMtKBDEQRYMoOj4-QemNootoZfKaLGXwBaKCCroKSTqtkZ7OmKQF_Xp7dNDa3M25VdRBaJfAMQEiTu5BCcATxZ4OgR4BSCaxWkEjwgTDlAFfRaM_ZANt5vwGQBgwto42COPAhZQjZO9L6l3pk8fGlfARymeVfGtKiF1-DfMql74OPlexq8b41RefokmfLWZ4EWEWavMV2wG4uXvmQ9X5eYmpMl0xL7ELueRttNaYNvudZW6hx_Ozh-klvr69uJqeXmNHqSyYWkvGzIw5k4oazx23vFYNWAITS5gVrm68GgtHZe2EkN46qTwV0tTOMmnoFjr43TtP8b33uehZyM63rel87LOWXKgJIXQA-S_oUsw5-UbPU5gN72gCeiFX_8jVC3MaqP6Rq9XQ21se6O3M1_-tpc0B2F8CJjvTNsl0LuR_jhMKw9BvaU2E2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75698113</pqid></control><display><type>article</type><title>Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>ELLIOTT, Richard L ; OLIVER, Robert M ; MACK, Christine M ; CASSELLA, James V ; LAFLAMME, Janet A ; GILLASPY, Melissa L ; HAMMOND, Marlys ; HANK, Richard F ; MAURER, Tristan S ; BAKER, Demetria L ; DASILVA-JARDINE, Paul A ; STEVENSON, Ralph W</creator><creatorcontrib>ELLIOTT, Richard L ; OLIVER, Robert M ; MACK, Christine M ; CASSELLA, James V ; LAFLAMME, Janet A ; GILLASPY, Melissa L ; HAMMOND, Marlys ; HANK, Richard F ; MAURER, Tristan S ; BAKER, Demetria L ; DASILVA-JARDINE, Paul A ; STEVENSON, Ralph W</creatorcontrib><description>A series of 2-heteroaryl-4-arylimidazoles with potent in vitro activity at the NPY5 receptor was developed. Introduction of electron-withdrawing groups on the 4-aryl ring led to a significant improvement of in vitro potency. Several analogues from this series had anorectic activity in rodent feeding models, but were also found to have undesired behavioral effects in spontaneous locomotor activity.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/S0960-894X(03)00747-9</identifier><identifier>PMID: 14505677</identifier><language>eng</language><publisher>Oxford: Elsevier</publisher><subject>Animals ; Behavior, Animal - drug effects ; Biological and medical sciences ; Feeding Behavior - drug effects ; Imidazoles - chemistry ; Imidazoles - pharmacology ; Medical sciences ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Rats ; Receptors, Neuropeptide Y - antagonists & inhibitors ; Structure-Activity Relationship</subject><ispartof>Bioorganic & medicinal chemistry letters, 2003-10, Vol.13 (20), p.3593-3596</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-3bb124a254793ae5c5b5d9f0b108b14b6cdfe926c37dc667ebc79e367adcb47a3</citedby><cites>FETCH-LOGICAL-c337t-3bb124a254793ae5c5b5d9f0b108b14b6cdfe926c37dc667ebc79e367adcb47a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15130000$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14505677$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ELLIOTT, Richard L</creatorcontrib><creatorcontrib>OLIVER, Robert M</creatorcontrib><creatorcontrib>MACK, Christine M</creatorcontrib><creatorcontrib>CASSELLA, James V</creatorcontrib><creatorcontrib>LAFLAMME, Janet A</creatorcontrib><creatorcontrib>GILLASPY, Melissa L</creatorcontrib><creatorcontrib>HAMMOND, Marlys</creatorcontrib><creatorcontrib>HANK, Richard F</creatorcontrib><creatorcontrib>MAURER, Tristan S</creatorcontrib><creatorcontrib>BAKER, Demetria L</creatorcontrib><creatorcontrib>DASILVA-JARDINE, Paul A</creatorcontrib><creatorcontrib>STEVENSON, Ralph W</creatorcontrib><title>Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A series of 2-heteroaryl-4-arylimidazoles with potent in vitro activity at the NPY5 receptor was developed. Introduction of electron-withdrawing groups on the 4-aryl ring led to a significant improvement of in vitro potency. Several analogues from this series had anorectic activity in rodent feeding models, but were also found to have undesired behavioral effects in spontaneous locomotor activity.</description><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Biological and medical sciences</subject><subject>Feeding Behavior - drug effects</subject><subject>Imidazoles - chemistry</subject><subject>Imidazoles - pharmacology</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Receptors, Neuropeptide Y - antagonists & inhibitors</subject><subject>Structure-Activity Relationship</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkMtKBDEQRYMoOj4-QemNootoZfKaLGXwBaKCCroKSTqtkZ7OmKQF_Xp7dNDa3M25VdRBaJfAMQEiTu5BCcATxZ4OgR4BSCaxWkEjwgTDlAFfRaM_ZANt5vwGQBgwto42COPAhZQjZO9L6l3pk8fGlfARymeVfGtKiF1-DfMql74OPlexq8b41RefokmfLWZ4EWEWavMV2wG4uXvmQ9X5eYmpMl0xL7ELueRttNaYNvudZW6hx_Ozh-klvr69uJqeXmNHqSyYWkvGzIw5k4oazx23vFYNWAITS5gVrm68GgtHZe2EkN46qTwV0tTOMmnoFjr43TtP8b33uehZyM63rel87LOWXKgJIXQA-S_oUsw5-UbPU5gN72gCeiFX_8jVC3MaqP6Rq9XQ21se6O3M1_-tpc0B2F8CJjvTNsl0LuR_jhMKw9BvaU2E2w</recordid><startdate>20031020</startdate><enddate>20031020</enddate><creator>ELLIOTT, Richard L</creator><creator>OLIVER, Robert M</creator><creator>MACK, Christine M</creator><creator>CASSELLA, James V</creator><creator>LAFLAMME, Janet A</creator><creator>GILLASPY, Melissa L</creator><creator>HAMMOND, Marlys</creator><creator>HANK, Richard F</creator><creator>MAURER, Tristan S</creator><creator>BAKER, Demetria L</creator><creator>DASILVA-JARDINE, Paul A</creator><creator>STEVENSON, Ralph W</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20031020</creationdate><title>Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists</title><author>ELLIOTT, Richard L ; OLIVER, Robert M ; MACK, Christine M ; CASSELLA, James V ; LAFLAMME, Janet A ; GILLASPY, Melissa L ; HAMMOND, Marlys ; HANK, Richard F ; MAURER, Tristan S ; BAKER, Demetria L ; DASILVA-JARDINE, Paul A ; STEVENSON, Ralph W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-3bb124a254793ae5c5b5d9f0b108b14b6cdfe926c37dc667ebc79e367adcb47a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Biological and medical sciences</topic><topic>Feeding Behavior - drug effects</topic><topic>Imidazoles - chemistry</topic><topic>Imidazoles - pharmacology</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Receptors, Neuropeptide Y - antagonists & inhibitors</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ELLIOTT, Richard L</creatorcontrib><creatorcontrib>OLIVER, Robert M</creatorcontrib><creatorcontrib>MACK, Christine M</creatorcontrib><creatorcontrib>CASSELLA, James V</creatorcontrib><creatorcontrib>LAFLAMME, Janet A</creatorcontrib><creatorcontrib>GILLASPY, Melissa L</creatorcontrib><creatorcontrib>HAMMOND, Marlys</creatorcontrib><creatorcontrib>HANK, Richard F</creatorcontrib><creatorcontrib>MAURER, Tristan S</creatorcontrib><creatorcontrib>BAKER, Demetria L</creatorcontrib><creatorcontrib>DASILVA-JARDINE, Paul A</creatorcontrib><creatorcontrib>STEVENSON, Ralph W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ELLIOTT, Richard L</au><au>OLIVER, Robert M</au><au>MACK, Christine M</au><au>CASSELLA, James V</au><au>LAFLAMME, Janet A</au><au>GILLASPY, Melissa L</au><au>HAMMOND, Marlys</au><au>HANK, Richard F</au><au>MAURER, Tristan S</au><au>BAKER, Demetria L</au><au>DASILVA-JARDINE, Paul A</au><au>STEVENSON, Ralph W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2003-10-20</date><risdate>2003</risdate><volume>13</volume><issue>20</issue><spage>3593</spage><epage>3596</epage><pages>3593-3596</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A series of 2-heteroaryl-4-arylimidazoles with potent in vitro activity at the NPY5 receptor was developed. Introduction of electron-withdrawing groups on the 4-aryl ring led to a significant improvement of in vitro potency. Several analogues from this series had anorectic activity in rodent feeding models, but were also found to have undesired behavioral effects in spontaneous locomotor activity.</abstract><cop>Oxford</cop><pub>Elsevier</pub><pmid>14505677</pmid><doi>10.1016/S0960-894X(03)00747-9</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0960-894X |
| ispartof | Bioorganic & medicinal chemistry letters, 2003-10, Vol.13 (20), p.3593-3596 |
| issn | 0960-894X 1464-3405 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_75698113 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Animals Behavior, Animal - drug effects Biological and medical sciences Feeding Behavior - drug effects Imidazoles - chemistry Imidazoles - pharmacology Medical sciences Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems Pharmacology. Drug treatments Rats Receptors, Neuropeptide Y - antagonists & inhibitors Structure-Activity Relationship |
| title | Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T15%3A02%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure-activity%20relationship%20studies%20on%202-heteroaryl-4-arylimidazoles%20NPY5%20receptor%20antagonists&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=ELLIOTT,%20Richard%20L&rft.date=2003-10-20&rft.volume=13&rft.issue=20&rft.spage=3593&rft.epage=3596&rft.pages=3593-3596&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/S0960-894X(03)00747-9&rft_dat=%3Cproquest_cross%3E75698113%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75698113&rft_id=info:pmid/14505677&rfr_iscdi=true |